Invasive breast cancer version 1.2016

William J. Gradishar; Benjamin O. Anderson; Ron Balassanian; Sarah L. Blair; Harold J. Burstein; Amy Cyr; Anthony D. Elias; William B. Farrar; Andres Forero; Sharon Hermes Giordano; Matthew Goetz; Lori J. Goldstein; Clifford A. Hudis; Steven J. Isakoff; P. Kelly Marcom; Ingrid A. Mayer; Beryl McCormick; Meena Moran; Sameer A. Patel; Lori J. Pierce; Elizabeth C. Reed; Kilian E. Salerno; Lee S. Schwartzberg; Karen Lisa Smith; Mary Lou Smith; Hatem Soliman; George Somlo; Melinda Telli; John H. Ward; Dorothy A. Shead; Rashmi Kumar

doi:10.6004/jnccn.2016.0037

Invasive breast cancer version 1.2016

William J. Gradishar, Benjamin O. Anderson, Ron Balassanian, Sarah L. Blair, Harold J. Burstein, Amy Cyr, Anthony D. Elias, William B. Farrar, Andres Forero, Sharon Hermes Giordano, Matthew Goetz, Lori J. Goldstein, Clifford A. Hudis, Steven J. Isakoff, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Meena Moran, Sameer A. Patel, Lori J. PierceElizabeth C. Reed, Kilian E. Salerno, Lee S. Schwartzberg, Karen Lisa Smith, Mary Lou Smith, Hatem Soliman, George Somlo, Melinda Telli, John H. Ward, Dorothy A. Shead, Rashmi Kumar

Medical Oncology

Research output: Contribution to journal › Review article › peer-review

221 Scopus citations

Abstract

Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The overall management of breast cancer includes the treatment of local disease with surgery, radiation therapy, or both, and the treatment of systemic disease with cytotoxic chemotherapy, endocrine therapy, biologic therapy, or combinations of these. This article outlines the NCCN Guidelines specific to breast cancer that is locoregional (restricted to one region of the body), and discusses the management of clinical stage I, II, and IIIA (T3N1M0) tumors. For NCCN Guidelines on systemic adjuvant therapy after locoregional management of clinical stage I, II and IIIA (T3N1M0) and for management for other clinical stages of breast cancer, see the complete version of these guidelines at NCCN.org.

Original language	English (US)
Pages (from-to)	324-354
Number of pages	31
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	14
Issue number	3
DOIs	https://doi.org/10.6004/jnccn.2016.0037
State	Published - Mar 1 2016

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2016.0037

Cite this

Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., Goetz, M., Goldstein, L. J., Hudis, C. A., Isakoff, S. J., Kelly Marcom, P., Mayer, I. A., McCormick, B., Moran, M., Patel, S. A., ... Kumar, R. (2016). Invasive breast cancer version 1.2016. JNCCN Journal of the National Comprehensive Cancer Network, 14(3), 324-354. https://doi.org/10.6004/jnccn.2016.0037

Gradishar, WJ, Anderson, BO, Balassanian, R, Blair, SL, Burstein, HJ, Cyr, A, Elias, AD, Farrar, WB, Forero, A, Giordano, SH, Goetz, M, Goldstein, LJ, Hudis, CA, Isakoff, SJ, Kelly Marcom, P, Mayer, IA, McCormick, B, Moran, M, Patel, SA, Pierce, LJ, Reed, EC, Salerno, KE, Schwartzberg, LS, Smith, KL, Smith, ML, Soliman, H, Somlo, G, Telli, M, Ward, JH, Shead, DA & Kumar, R 2016, 'Invasive breast cancer version 1.2016', JNCCN Journal of the National Comprehensive Cancer Network, vol. 14, no. 3, pp. 324-354. https://doi.org/10.6004/jnccn.2016.0037

@article{07b099ed6cc74a1b880f0d14e33589bc,

title = "Invasive breast cancer version 1.2016",

abstract = "Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The overall management of breast cancer includes the treatment of local disease with surgery, radiation therapy, or both, and the treatment of systemic disease with cytotoxic chemotherapy, endocrine therapy, biologic therapy, or combinations of these. This article outlines the NCCN Guidelines specific to breast cancer that is locoregional (restricted to one region of the body), and discusses the management of clinical stage I, II, and IIIA (T3N1M0) tumors. For NCCN Guidelines on systemic adjuvant therapy after locoregional management of clinical stage I, II and IIIA (T3N1M0) and for management for other clinical stages of breast cancer, see the complete version of these guidelines at NCCN.org.",

author = "Gradishar, {William J.} and Anderson, {Benjamin O.} and Ron Balassanian and Blair, {Sarah L.} and Burstein, {Harold J.} and Amy Cyr and Elias, {Anthony D.} and Farrar, {William B.} and Andres Forero and Giordano, {Sharon Hermes} and Matthew Goetz and Goldstein, {Lori J.} and Hudis, {Clifford A.} and Isakoff, {Steven J.} and {Kelly Marcom}, P. and Mayer, {Ingrid A.} and Beryl McCormick and Meena Moran and Patel, {Sameer A.} and Pierce, {Lori J.} and Reed, {Elizabeth C.} and Salerno, {Kilian E.} and Schwartzberg, {Lee S.} and Smith, {Karen Lisa} and Smith, {Mary Lou} and Hatem Soliman and George Somlo and Melinda Telli and Ward, {John H.} and Shead, {Dorothy A.} and Rashmi Kumar",

note = "Publisher Copyright: {\textcopyright} JNCCN - Journal of the National Comprehensive Cancer Network.",

year = "2016",

month = mar,

day = "1",

doi = "10.6004/jnccn.2016.0037",

language = "English (US)",

volume = "14",

pages = "324--354",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "3",

}

TY - JOUR

T1 - Invasive breast cancer version 1.2016

AU - Gradishar, William J.

AU - Anderson, Benjamin O.

AU - Balassanian, Ron

AU - Blair, Sarah L.

AU - Burstein, Harold J.

AU - Cyr, Amy

AU - Elias, Anthony D.

AU - Farrar, William B.

AU - Forero, Andres

AU - Giordano, Sharon Hermes

AU - Goetz, Matthew

AU - Goldstein, Lori J.

AU - Hudis, Clifford A.

AU - Isakoff, Steven J.

AU - Kelly Marcom, P.

AU - Mayer, Ingrid A.

AU - McCormick, Beryl

AU - Moran, Meena

AU - Patel, Sameer A.

AU - Pierce, Lori J.

AU - Reed, Elizabeth C.

AU - Salerno, Kilian E.

AU - Schwartzberg, Lee S.

AU - Smith, Karen Lisa

AU - Smith, Mary Lou

AU - Soliman, Hatem

AU - Somlo, George

AU - Telli, Melinda

AU - Ward, John H.

AU - Shead, Dorothy A.

AU - Kumar, Rashmi

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The overall management of breast cancer includes the treatment of local disease with surgery, radiation therapy, or both, and the treatment of systemic disease with cytotoxic chemotherapy, endocrine therapy, biologic therapy, or combinations of these. This article outlines the NCCN Guidelines specific to breast cancer that is locoregional (restricted to one region of the body), and discusses the management of clinical stage I, II, and IIIA (T3N1M0) tumors. For NCCN Guidelines on systemic adjuvant therapy after locoregional management of clinical stage I, II and IIIA (T3N1M0) and for management for other clinical stages of breast cancer, see the complete version of these guidelines at NCCN.org.

AB - Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The overall management of breast cancer includes the treatment of local disease with surgery, radiation therapy, or both, and the treatment of systemic disease with cytotoxic chemotherapy, endocrine therapy, biologic therapy, or combinations of these. This article outlines the NCCN Guidelines specific to breast cancer that is locoregional (restricted to one region of the body), and discusses the management of clinical stage I, II, and IIIA (T3N1M0) tumors. For NCCN Guidelines on systemic adjuvant therapy after locoregional management of clinical stage I, II and IIIA (T3N1M0) and for management for other clinical stages of breast cancer, see the complete version of these guidelines at NCCN.org.

UR - http://www.scopus.com/inward/record.url?scp=84961577176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961577176&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2016.0037

DO - 10.6004/jnccn.2016.0037

M3 - Review article

C2 - 26957618

AN - SCOPUS:84961577176

SN - 1540-1405

VL - 14

SP - 324

EP - 354

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 3

ER -

Invasive breast cancer version 1.2016

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this